Clinical Research & Pipeline Products

Fundación Beckley Med is a Barcelona-based non-profit organisation at the intersection of psychedelic science, mental health treatment, and therapist training. Founded in the spirit of Amanda Feilding's decades of work with the Oxford-based Beckley Foundation, it operates independently and offers an International Training Program in Psychedelic Therapies with institutional partnerships including MAPS, Grof Legacy, and CIIS. The foundation also conducts research into psychedelic-assisted therapy and has collaborated with the CITA Clinic to provide ketamine treatment for treatment-resistant depression.

COMPASS Pathways is a UK-listed biopharmaceutical company developing COMP360 synthetic psilocybin therapy for treatment-resistant depression, with two successful Phase 3 trials making it the leading candidate for the first regulatory approval of a classic psychedelic medicine.

Clerkenwell Health (trading as Clerkenwell Clinics Limited) is a UK-based clinical research organisation that designs and runs psychiatry and central nervous system (CNS) clinical trials and provides psychedelic-assisted therapy services. It operates specialist clinics and site networks to support early-phase CNS and mental-health research.

The Ketamine Research Institute is a US-based clinical research organization developing precision medicine approaches to ketamine infusion therapy, studying optimized dosing protocols to treat depression and offering clinician training in evidence-based ketamine practice.

Numinus Wellness Inc. is a Vancouver-based mental health company focused on psychedelic-assisted therapy: it provides practitioner training, clinical research services, and (formerly) operated clinics and a Health Canada‑licensed bioscience laboratory for psychedelic research and product development.